RADIESSE® Voice and RADIESSE® Voice Gel Implants for Vocal Fold Augmentation

Radiesse Voice Products

The RADIESSE Voice injectable implant contains synthetic Calcium Hydroxylapatite (CaHA) microspheres, which have a diameter of 25–45 micron, suspended in an aqueous resorbable carrier gel. The product is injectable through a 25-gauge needle. RADIESSE Voice implant provides vocal fold augmentation with results that typically lasts 1 year.

The RADIESSE Voice Gel injectable implant contains synthetically derived polymers, with no CaHA microspheres, and it is suitable for short term vocal fold augmentation in patients where reversible nerve damage is suspected, or in patients wishing a short term augmentation before deciding to have a long term augmentation done with the RADIESSE Voice implant.

RADIESSE Voice and RADIESSE Voice Gel implants are sold with either a malleable transoral needle or a non-coring percutaneous needle.

Unique Mechanism of Action

Over time the RADIESSE Voice implant carrier gel is resorbed and the Calcium Hydroxylapatite particles support in-growth of new collagen. The durable Calcium Hydroxylapatite microspheres degrade slowly over years for a long-lasting effect. The implant remains soft after injection and does not ossify.

In clinical testing and routine clinical use for over 6 years, no implant migration or evidence of granuloma formation has been observed.

Clinically Proven Results

Proven effective – in clinical testing with 12 months follow up, the majority of patients treated with the RADIESSE Voice implant reported that their voice was greatly or significantly improved. ¹

Proven safe - no granuloma formation or major complications have been reported. ¹

Proven long-lasting – results typically last more than 12 months^1,4.

Convenient and Easy-to-Use

No fat harvesting or processing

No preparation or mixing – supplied in ready-to-use 1.0 cc syringe with injection needle

No refrigeration – store at room temperature

No allergy testing – contains no animal or human components

No waiting – injection can be performed in-office in 30 minutes or less

Injection Techniques

RADIESSE products can be injected through a 25-gauge needle in the operating room or in the office using a trans-thyroid cartilage, trans-cricothyroid membrane or thyrohyoid approach^2,3.